Chang of Inflannnatory Factors in Patients with Severe Valve Disease
程光存,严中亚,吴一军,雷虹,孙云,卢中,郑理,朱正艳,姜波
DOI: https://doi.org/10.3969/j.issn.1007-5062.2008.03.002
2008-01-01
Abstract:Objective:Changes of inflammatory factors and their effects were studied in patients with severe valve disease.Method:Sixty patients with valve disease who receive valve replacement for the first time were divided into three groups: Ulinastatin group(group A), Ulinastatin and Aprotinin group (group B) and control group (group C). Each group had 20 patients. Blood samples were taken from the central vein before anesthesia, 30 minutes after the beginning of the cardiopulmonary bypass(CPB), 30 minutes after the end of the CPB and 24 hours after the operation, The serum levels of ALT, BUN, CR, AST, CK-MB and tumor necrosis factor(TNFA-α), interleukin 6(IL-6), interleukin 8(IL-8), interleukin 10(IL-10)were detected respectively.Result:After the operation, serum levels of ALT, BUN, CR, AST, CK-MB increased in all three groups. But the serum levels of ALT, BUN, CR, AST, CK-MB were significant higher in group C than in other two groups (P0.01). Serum levels of ALT, BUN, CR, AST, CK-MB in group A were significant different from those in group B. Serum levels of TNFA-α, IL-6, IL-8 increased after the beginning of the operation and reach peak value 1 hour after the opening of the aortic clamp. Serum levels of TNFA-α, IL-6, IL-8 in group C is significantly higher than group A and group B. IL-10 increased in all the three groups. The levels of IL-10 were significantly higher in groups A and group B than that in group C (P0.01).Conclusion:Ulinastatin and Aprotinin could decrease the serum levels of TNFA-α, IL-6,IL-8 in patients with severe valve disease who receive valve replacement. The secrete of inflammatory inhibitive factor IL-10 was also increased. The inflammatory response induced by CPB was decreased and recovery from the operation was promoted. Functions of protection should be further investigated.